Login / Signup

Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).

Shahariar Mohammed FahimAhmed Ullah MishukNing ChengRichard HansenAngela I CalderónJingjing Qian
Published in: Expert opinion on drug safety (2018)
This study identified potential protective and risk signals for AEs with concomitant use of BDS and anticancer drugs.
Keyphrases
  • adverse drug
  • drug administration
  • human health
  • drug induced
  • emergency department
  • risk assessment
  • electronic health record